Clinical Trials Browser

OTHER × Osteosarcoma × Bevacizumab × Clear all

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma

NCT00667342 2023-08-07

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

Phase 2 Completed

43 enrolled 25 charts

Osteosarcoma, Histiocytoma, Malignant Fibrous